Pulmonary Artery Catheter Monitoring in Patients with Cardiogenic Shock: Time for a Reappraisal?
Maurizio Bertaina, Alessandro Galluzzo, Nuccia Morici...
https://pubmed.ncbi.nlm.nih.gov/35541286/Actively Recruiting
Led by Bach Mai Hospital · Updated on 2025-07-14
108
Participants Needed
1
Research Sites
4 weeks
Total Duration
This research investigates the use of the Swan-Ganz catheter, a specialized pulmonary artery catheter, to improve heart and circulation monitoring in adults experiencing cardiogenic shock caused by acute myocardial infarction AMI. Cardiogenic shock is a life-threatening condition where the heart cannot supply enough blood to organs, often following a severe heart attack. The study aims to evaluate how continuous hemodynamic data from the catheter can guide treatment and improve patient outcomes. Participants will have the Swan-Ganz catheter inserted through the neck or chest veins upon admission to the intensive care unit. This catheter continuously measures pressures in the heart and lungs, cardiac output, and oxygen saturation in the blood. These measurements help doctors adjust medications like inotropes and vasopressors, fluids, and ventilation support to stabilize heart function. The study follows a goal-directed treatment plan with specific targets for blood pressure, cardiac index, and oxygen levels. All patients also receive standard care for AMI. No control group is included. During the study, patients will be closely monitored with repeated hemodynamic measurements at scheduled intervals up to 24 hours after catheter insertion. Researchers will track treatment responses, 30-day survival, length of ICU stay, and any catheter-related complications. Data analysis will explore factors linked to successful heart stabilization. Participation lasts through hospital care with voluntary consent and confidentiality safeguards. Patients may withdraw anytime without affecting their usual medical treatment.
CONDITIONS
The Role of Swan-Ganz Catheter in Hemodynamic Resuscitation for Patients With Cardiogenic Shock
T
Thang Xuan Pham, MD, PhD Candidate
T
Tuan Anh Nguyen, Prof.PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Bach Mai Hospital
Lead Sponsor
Hanoi Medical University
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 30 days
Participants undergo insertion of a Swan-Ganz catheter via the internal jugular or subclavian vein to enable continuous invasive hemodynamic monitoring. This catheter measures pressures and cardiac output to guide goal-directed resuscitation efforts.
Continuous monitoring during ICU stay
Duration - Up to 30 days
Participants receive goal-directed hemodynamic resuscitation guided by continuous Swan-Ganz catheter measurements, including titration of vasopressors, inotropes, and fluid management to stabilize heart function and circulation.
Continuous care during ICU stay
Duration - Up to 30 days
Participants are monitored for catheter-related complications, ICU length of stay, and clinical outcomes including survival and organ function up to 30 days after catheter insertion.
Ongoing assessments throughout hospital stay
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Maurizio Bertaina, Alessandro Galluzzo, Nuccia Morici...
https://pubmed.ncbi.nlm.nih.gov/35541286/A Reshad Garan, Manreet Kanwar, Katherine L Thayer...
https://pubmed.ncbi.nlm.nih.gov/33121702/Ana Beatriz B A C Réa, Vesna Mihajlovic, Julie K K Vishram-Nielsen...
https://pubmed.ncbi.nlm.nih.gov/38092192/Behnam N Tehrani, Alexander G Truesdell, Matthew W Sherwood...
https://pubmed.ncbi.nlm.nih.gov/30947919/Rupert Fincke, Judith S Hochman, April M Lowe...
https://pubmed.ncbi.nlm.nih.gov/15261929/Dhaval Kolte, Sahil Khera, Wilbert S Aronow...
https://pubmed.ncbi.nlm.nih.gov/24419737/Bernard S Kadosh, David D Berg, Erin A Bohula...
https://pubmed.ncbi.nlm.nih.gov/37318422/Robert J Goldberg, Frederick A Spencer, Joel M Gore...
https://pubmed.ncbi.nlm.nih.gov/19237658/Shashank S Sinha, Carolyn M Rosner, Behnam N Tehrani...
https://pubmed.ncbi.nlm.nih.gov/35510546/Tae Kyung Yoo, Satoshi Miyashita, Farideh Davoudi...
https://pubmed.ncbi.nlm.nih.gov/37100652/Bach Mai Hospital
Lead Sponsor
Hanoi Medical University
Collaborating Sponsor